Terry L. Smith

A note on quantifying follow-up in studies of failure time

M. Schemper, Terry L. Smith · Controlled Clinical Trials · 1996 · 2.5K citations

Public Health, Biostatistics, Survival Analysis +7

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al. · Journal of Clinical Oncology · 1999 · 1.3K citations

Medicine, Oncology, Surgery +17

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

Hagop M. Kantarjian, Susan O’Brien, Terry L. Smith et al. · Journal of Clinical Oncology · 2000 · 795 citations

Medicine, Hematology, Oncology +15

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

Philip Greenberg, Gabriel N. Hortobágyi, Terry L. Smith et al. · Journal of Clinical Oncology · 1996 · 754 citations

Medicine, Oncology, Chemotherapy +11